Intranasal Vaccine Innovation: Shielding Against COVID-19 Across Mice Age Groups

intranasal vaccine

Although global concerns surrounding COVID-19 have somewhat waned, the threat persists, particularly for those with compromised immune systems or individuals over 65 years old.

Vaccines have proven effective in preventing severe illness and fatalities. Yet, enhancing their capacity to halt SARS-CoV-2 transmission at the upper respiratory tract’s point of entry remains a priority.